4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-25-083321
Director sold 3 shares at $30.48 ($91)
From the SEC's structured data for this filing
Trades in this filing
GANNON STEVEN · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-05 | Sale : show line 1 in the form | −3 | $30.48 | $91 | 7,141 | D |
| Open-market sales · 3 sh · avg $30.48 · $91 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-05 | Grant or award : show line 2 in the form Share Option (Right to Buy) | +17,012 | 17,012 | D |
| 2025-06-05 | Grant or award : show line 3 in the form Restricted Share Units | +2,645 | 2,645 | D |
Loading xslF345X05/ownership.xml…